Suppliers

Eppendorf Bioprocess Solutions

Scientists from industry and academia trust Eppendorf bioprocess solutions for the cultivation of mammalian, insect, plant, and stem cells, as well as bacteria, yeasts, and fungi.

Headlines

Biologics driving M&A as Agilent snaps up specialist BIOVECTRA for $925 million
Third Arc Bio raises $165M series A to develop biologics for cancer and immunology
Alvotech and Stada debut uzpruvo, the first ustekinumab biosimilar in Europe
Rona Therapeutics raises $35M in series A+ to advance metabolic siRNA therapeutics
Pluri’s CDMO arm takes on ALS and diabetes in cell therapy deal
Ionis announces positive early results for Angelman syndrome therapy
CordenPharma invests €900M in expanding peptide platform to meet GLP-1 drug demand
Top 5 CDMOs driving advanced therapies to market amid rising demand and challenges
Roche’s oral GLP-1 receptor agonist shows promising early weight loss results in phase 1
FDA delays approval of Novo Nordisk’s weekly insulin until requests are met
Lexeo’s gene therapy shows promising phase 1/2 results for Friedreich's ataxia cardiomyopathy
Rentschler opens advanced therapy production line as CDMO demand surges
HilleVax halts development of world’s most advanced norovirus vaccine after phase 2 failure

Featured Suppliers

All

Nicoya Lifesciences
Thermo Fisher Scientific Gibco Culture for Bioprocessing
WuXi AppTec

Suppliers

Eppendorf Bioprocess Solutions

Follow us

Most popular News

Headlines

Featured Suppliers

BioPharma-Reporter

Resources